ISO 20417:2026 Has Been Published: What Medical Manufacturers Need to Know
The second edition of ISO 20417, Medical devices – Information to be supplied by the manufacturer, has now been published, replacing the 2021 edition.
The updated standard includes several technical revisions that clarify and refine the requirements for information supplied with medical devices and accessories. While the changes are not extensive, they are relevant for manufacturers that apply ISO 20417 as part of their Quality Management System (QMS) or supply devices to international markets.
What is ISO 20417?
ISO 20417 specifies the general requirements for information supplied by the manufacturer throughout the lifecycle of a medical device. This includes:
- Product labels
- Packaging information
- Device markings
- Instructions for Use (IFUs)
- Accompanying documentation
- Information necessary for the safe and effective use of the device
Rather than prescribing device-specific labelling requirements, the standard provides a framework that supports consistent development of information supplied with medical devices, complements other regulatory requirements and international standards.
Why is it important?
Providing clear, accurate and consistent information is essential to the safe and effective use of medical devices.
Although compliance with ISO 20417 is not specifically required under Australian legislation, the principles of the standard align closely with the Therapeutic Goods Administration (TGA) Essential Principles relating to labelling and information supplied with medical devices. It is also widely recognised internationally and is commonly used by manufacturers supplying products to multiple markets.
What’s changed in ISO 20417:2026?
The 2026 edition is a technical revision rather than a complete rewrite. Key updates include:
Updated normative references
References have been updated to reflect the latest editions of related standards and regulatory expectations.
Introduction of the “applicable policy” concept
A new concept of applicable policy has been introduced to clarify how manufacturers should address market-specific regulatory requirements while maintaining compliance with the standard.
Streamlined guidance
Several informative annexes included in the 2021 edition have been removed, simplifying the structure of the standard and reducing duplication.
Improved clarity
Several clauses have been revised to improve clarity and consistency regarding manufacturer responsibilities and the information that accompanies medical devices.
What does this mean for Australian manufacturers and sponsors?
For most Australian manufacturers and sponsors, the publication of ISO 20417:2026 is unlikely to require immediate changes.
Instead, the revised edition provides an opportunity to become familiar with the updates and consider them during future reviews of labelling, IFUs and QMS documentation. Organisations supplying products internationally may also see overseas manufacturers gradually adopt the revised edition as part of their document maintenance activities.
Final thoughts
The publication of ISO 20417:2026 reflects the ongoing evolution of internationally recognised best practice for medical device labelling and accompanying information.
While there is no need for immediate action solely because a new edition has been released, manufacturers should remain aware of the changes and consider them as part of future documentation updates. Doing so can help maintain consistency across global markets and support ongoing regulatory compliance.
How KD&A can help
Whether you are developing a new medical device, updating your technical documentation or reviewing your labelling against Australian requirements, KD&A can provide independent regulatory advice tailored to your products and target markets.
Our team assists manufacturers and Australian sponsors with:
- Medical device labelling and IFU reviews
- Essential Principles compliance assessments
- ISO 13485 QMS
- Technical documentation reviews
- Australian TGA regulatory compliance
- Regulatory strategies for global market access
If you would like to understand how ISO 20417:2026 may fit within your existing QMS or documentation lifecycle, our regulatory consultants are available to help you assess the changes and determine an approach that is appropriate for your organisation.
